Ronald V. Vollenhoven

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Targeting CD40 with dapirolizumab pegol: a new treatment for systemic lupus erythematosus.

Targeting CD40 with dapirolizumab pegol: a new treatment for systemic lupus erythematosus.

Journal: Lancet (London, England)

Published: May 14, 2026

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: long-term efficacy and safety through 5 years in the SELECT-EARLY study.

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: long-term efficacy and safety through 5 years in the SELECT-EARLY study.

Journal: Modern rheumatology

Published: February 12, 2026

Biological impact of iberdomide in patients with active systemic lupus erythematosus.

Biological impact of iberdomide in patients with active systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: January 21, 2022

Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.

Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.

Journal: Lupus

Published: May 07, 2021

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Journal: Clinical pharmacology and therapeutics

Published: July 09, 2018

Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.

Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.

Journal: BMJ open

Published: June 12, 2017

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers.

Journal: Annals of the rheumatic diseases

Published: July 02, 2016

Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.

Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.

Journal: Lupus

Published: January 09, 2014

Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.

Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.

Journal: Lupus

Published: June 14, 2013

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.

Journal: BMC immunology

Published: April 15, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026